지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
The causes of ischemic stroke are widely diverse, ranging from large artery atherosclerosis to cardioembolism, and it is important to use preventive therapy toward the goal reducing the future risk of recurrent ischemic stroke, myocardial infarction, and vascular death. Antithrombotic therapy is one of the fundamental medical approaches for secondary prevention of ischemic stroke, which is broadly divided into two general categories, those that exert their effect via platelet inhibition (antiplatelet agents), and those that influence various factors in the clotting cascade (anticoagulants). In general, the clinical guidelines recommend antiplatelet agents for patients with non-cardioembolic stroke, while anticoagulants is indicated for patients with presumed or proven cardioembolic stroke. Many clinical trials have attempted to test the efficacy and safety of antithrombotics in ischemic stroke. This review will discuss on currently available antithrombotic agents that have demonstrated efficacy for secondary prevention of ischemic stroke.
목차
등록된 정보가 없습니다.
참고문헌 (21)
참고문헌 신청
/ 1997 / CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group
/ 1997 / The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Interna
Algra A / 1996 / Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia / J Neurol Neurosurg Psychiatry 60 : 197 ~ 199
Antithrombotic Trialists’ Collaboration / 2002 / Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and
Bhatt DL / 2001 / Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery / Circulation 103 : 363 ~ 368
/ 1997 / The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Interna
Algra A / 1996 / Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia / J Neurol Neurosurg Psychiatry 60 : 197 ~ 199
Antithrombotic Trialists’ Collaboration / 2002 / Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and
Bhatt DL / 2001 / Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery / Circulation 103 : 363 ~ 368
이 논문의 저자 정보
최근 본 자료
댓글(0)
0